Ruth Sager

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Sotiropoulou G, Kono M, Anisowicz A, et al. (2002) Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer. Molecular Medicine (Cambridge, Mass.). 8: 42-55
Zhang M, Shi Y, Magit D, et al. (2000) Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Oncogene. 19: 6053-8
Zhang M, Magit D, Botteri F, et al. (1999) Maspin plays an important role in mammary gland development. Developmental Biology. 215: 278-87
Anisowicz A, Sotiropoulou G, Sager R. (1999) Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter. Molecular Medicine (Cambridge, Mass.). 5: 526-41
Martin KJ, Sager R. (1998) Expression genetics in cancer research, prognosis, and therapy. Advances in Experimental Medicine and Biology. 451: 1-7
Martin KJ, Kwan CP, Nagasaki K, et al. (1998) Down-regulation of laminin-5 in breast carcinoma cells. Molecular Medicine (Cambridge, Mass.). 4: 602-13
Martin KJ, Kwan CP, O'Hare MJ, et al. (1998) Identification and verification of differential display cDNAs using gene-specific primers and hybridization arrays. Biotechniques. 24: 1018-26
Zhang M, Martin KJ, Sheng S, et al. (1998) Expression genetics: a different approach to cancer diagnosis and prognosis. Trends in Biotechnology. 16: 66-71
Sheng S, Truong B, Fredrickson D, et al. (1998) Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin. Proceedings of the National Academy of Sciences of the United States of America. 95: 499-504
Sager R, Sheng S, Pemberton P, et al. (1997) Maspin. A tumor suppressing serpin. Advances in Experimental Medicine and Biology. 425: 77-88